Peripheral Artery Tonometry in Children With Type 1 Diabetes and Obese Children

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by Universitaire Ziekenhuizen Leuven.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Universitaire Ziekenhuizen Leuven
ClinicalTrials.gov Identifier:
NCT01267591
First received: December 27, 2010
Last updated: NA
Last verified: January 2009
History: No changes posted
  Purpose

Background: The reactive hyperemia-peripheral artery tonometry (RH-PAT) is a newly developed method for noninvasive endothelial function assessment.

Objective: The goal of this study is to determine whether a significant difference in RH-PAT score is present between adolescents with type 1 diabetes (T1D) in comparison with controls. We will also compare RH-PAT scores in obese adolescents versus controls.


Condition
Peripheral Artery Tonometry
Diabetes
Children
Obesity

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Peripheral Artery Tonometry in Children With Type 1 Diabetes and Obese Children.

Resource links provided by NLM:


Further study details as provided by Universitaire Ziekenhuizen Leuven:

Primary Outcome Measures:
  • RHPAT [ Time Frame: 2 years ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 70
Study Start Date: January 2009
Groups/Cohorts
control
type 1 diabetes
obesity

  Eligibility

Ages Eligible for Study:   12 Years to 19 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

children seen at consultation in University Hospital

Criteria

Inclusion Criteria:

  • 12-19 years of age

Exclusion Criteria:

  • type 2 diabetes; obesity in group of type 1 diabetes
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01267591

Contacts
Contact: kristina casteels, MD Phd 00-32-16-343801

Locations
Belgium
University Hospital Leuven Recruiting
Leuven, Belgium
Contact: kristina casteels, MD PhD    00-32-16-343801      
Sponsors and Collaborators
Universitaire Ziekenhuizen Leuven
  More Information

No publications provided

Responsible Party: kristina casteels, Pediatrie, UZLeuven
ClinicalTrials.gov Identifier: NCT01267591     History of Changes
Other Study ID Numbers: UZLeuven
Study First Received: December 27, 2010
Last Updated: December 27, 2010
Health Authority: Belgium: Ethics Committee

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 1
Obesity
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Autoimmune Diseases
Immune System Diseases
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms

ClinicalTrials.gov processed this record on August 27, 2014